Portaria conjunta nº 11, de 2 de julho de 2021

Thumbnail Image

Files

informe-sus-onco-julho-2021_0.pdf (571.74 KB)

Date

2021-07

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

INCA

Abstract

Description

3 p.: il. p&b.

Keywords

Leucemia Linfoblástica Aguda, Mesilato de Imatinib, Neoplasias, Imatinib Mesylate, Leucemia-Linfoma Linfoblástico de Células Precursoras, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms

Citation

URI

http://sr-vmlxaph03:8080/jspui/handle/123456789/3817

Collections

Informe SUS - ONCO 2021

Endorsement

Review

Supplemented By

Referenced By